Navigation Links
Anonymization remains a powerful approach to protecting the privacy of health information
Date:12/8/2011

OTTAWA, ON December 8, 2011 De-identification of health data has been crucial for all types of health research, but recent articles in medical and scientific literature have suggested that de-identification methods do not sufficiently protect the identities of individuals and can be easily reversed. A recent review conducted by researchers at CHEO entitled "A Systematic Review of Re-identification Attacks on Health Data" and published in PLoS ONE, did not uncover evidence to support this. "If re-identification rates were as high as some of these articles suggest, it would be worrisome," says lead author, Dr. Khaled El-Emam. "But our review did not support these claims there is no broad empirical support for a failure of anonymization."

Such a failure would have significant policy implications. For example, it may become necessary to obtain patient consent before data is released (a time-consuming undertaking), incentive to de-identify would decline, and the likelihood of breaches would increase. For this reason, Dr. El-Emam and his team conducted a review that set out to characterize known re-identification attacks on health data and compare them to attacks on other types of data, calculate the number of records correctly identified in these attacks, and assess whether the results indicate a weakness in current de-identification methods.

After identifying 14 relevant studies and analyzing them in detail, the group was unable to find convincing evidence that existing de-identification methods are not effective. Few of these attacks involved health data which is naturally protected more strenuously. Secondly, many of the attacks were on small databases with large confidence intervals around their success rates. Most importantly, the majority of re-identified data was not de-identified according to existing standards. "Of the 24 studies we examined, only six were attacks on health data and only one of these was de-identified according to standards," Dr. El-Emam points out. "In that particular study, the proportion of correctly re-identified records was very low: about 0.013%."

In certain well-publicized re-identification attacks, adversaries were able to make use of such information as an individual's date of birth, gender, and residential zip code. Since these 3 features were not modified in any way, the database would not meet basic standards for de-identification. If anything, such a breach serves to underscore the importance of implementing existing de-identification standards.

Dr. El-Emam concludes by saying that in order to have a more accurate picture of the extent to which de-identification protects against real attacks, future research on re-identification attacks should focus on large databases that have been de-identified according to existing standards, and that success rates should be correlated with how well de-identification was performed. In the meantime, it is suggested that data custodians continue to de-identify using current best practices.


'/>"/>

Contact: Adrienne Vienneau
avienneau@cheo.on.ca
613-737-7600 x4144
Children's Hospital of Eastern Ontario Research Institute
Source:Eurekalert

Related medicine news :

1. A Healthy Diet Remains Your Best Weapon Against the #1 Killer: Heart Disease
2. JDR increases its 5-Year SIF and remains number one dental journal of 64 in its category
3. Green And Greener Survey Shows Hospitals Embrace Environmentally Sustainable Practices, Though Room for Improvement Remains
4. Lack of insurance coverage remains obstacle to wider colorectal cancer screening with CT colonography
5. Surgery or stenting for carotid artery disease? Question remains
6. Results of the placement of multiple endoscopic stents for postoperative biliary strictures remains excellent after long-term follow-up
7. Adults in Puerto Rico aware of genetic testing, but use remains low
8. Religious Identity Remains Constant in Teen Years: Study
9. Benefit of blood glucose lowering to near-normal levels remains unclear
10. Evidence in the field of CVD in pregnancy is sparse, but the condition remains a concern:
11. New report: US investment in health research remains stagnant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology: